Unternehmens-Analyse: BASF

Zusammenfassung

BASF SE is a diversified chemicals group with an integrated “Verbund” production model (large-scale, interconnected sites that share feedstocks, energy and logistics) and a portfolio spanning Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. Core competencies include process engineering, scale economics, integrated asset utilization, and formulation/application know-how in downstream specialties. Strategically, BASF has been executing portfolio optimization and restructuring to improve returns and reduce complexity, while continuing large capex programs (notably the Zhanjiang Verbund site ramp-up) and cost programs under its “Winning Ways” priorities. (basf.com) Market position remains anchored by global scale in commodity and performance chemicals and a broad customer footprint across industrial end-markets. Competitive advantages are primarily structural (integration, asset base, and customer relationships) rather than purely product-differentiation; this makes earnings sensitive to cycle, energy/feedstock spreads, and utilization rates. Recent months’ developments were dominated by stronger-than-expected operating performance and a major portfolio milestone: BASF reported preliminary Q2 2026 EBITDA before special items of ~€2.4bn (above consensus) and raised full-year 2026 EBITDA before special items guidance to €6.9–€7.7bn (from €6.2–€7.0bn), while reiterating free cash flow guidance of €1.5–€2.3bn. (basf.com) Reported earnings were boosted by the Coatings transaction with Carlyle, which closed June 30, 2026 and drove a large disposal gain (pre-tax ~€3.9bn; after-tax disposal gain ~€3.5bn cited in H1 context). This lifted Q2 net income to an expected ~€4.1bn and H1 income after taxes to ~€5.1bn, but investors should separate this one-off from underlying operating momentum. (basf.com) Operationally, H1 2026 sales increased to €33.2bn (+€1.9bn vs H1 2025) on positive volume and price effects; H1 EBITDA before special items improved to €4.8bn (+€715m). Q2 sales were ~€17.2bn (+€2.4bn YoY) and Q2 EBITDA before special items improved by ~€854m YoY to ~€2.4bn. (basf.com) Valuation metrics (EUR) indicate a mid-cycle multiple: trailing P/E ~21.7x and forward P/E ~18.0x (S&P Global Market Intelligence via StockAnalysis, updated Sep 21, 2026). The market cap is ~€44.2bn. Analyst-compiled target price averages around €53.45 (high €64, low €40). With the stock around ~€51.8 (Sep 22, 2026 snapshot), implied upside to the average target is modest, suggesting a balanced risk/reward profile near consensus. (stockanalysis.com) Short- to medium-term outlook is supported by raised EBITDA guidance and ongoing cost/portfolio actions, but tempered by cash flow volatility (Q2 free cash flow ~-€0.2bn; H1 free cash flow ~-€1.6bn) and cyclical exposure. The key investment question is whether improved utilization/cost execution can sustain EBITDA within the raised range while converting to the reiterated full-year free cash flow target. (basf.com)

Key Takeaways

1. BASF raised 2026 EBITDA before special items guidance to €6.9–€7.7bn after Q2 2026 came in above consensus on an operating basis. (basf.com)
2. Reported net income in Q2/H1 2026 was heavily influenced by the Coatings disposal gain; underlying operating performance should be assessed using EBITDA before special items and segment trends. (basf.com)
3. H1 2026 showed improving top line and profitability: sales €33.2bn (+€1.9bn YoY) and EBITDA before special items €4.8bn (+€715m). (basf.com)
4. Cash conversion remains a near-term watch item: Q2 free cash flow was negative and H1 free cash flow was -€1.6bn, even as full-year FCF guidance stayed at €1.5–€2.3bn. (basf.com)
5. Valuation looks neither distressed nor expensive versus near-term earnings expectations (trailing P/E ~21.7x; forward P/E ~18.0x), and the stock trades close to the average published target price (~€53.45). (stockanalysis.com)

Action-Ideen

Contrarian Insights

• • The headline profit strength in 2026 is less informative than it appears: Q2/H1 net income was materially lifted by the Coatings disposal gain, while free cash flow in Q2 and H1 was negative. A contrarian read is that the market may be underweighting cash conversion risk versus EBITDA optics. (basf.com)
• • Because the stock trades close to the average published target price (~€53.45) and valuation multiples are not depressed (forward P/E ~18x), a contrarian stance is that the upgraded guidance is already substantially reflected in price—limiting upside unless cash flow delivery improves materially. (basf.com)